cp wire

CP Wire Articles

Ironwood Initiates Ph III Study of Linaclotide in IBS-C

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced  on 7/16/18 the initiation of a Phase IIIb clinical trial evaluating the efficacy and safety of linaclotide 290 mcg on multiple abdominal... read more

Mon, 07/16/18 - 09:06 am
Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories
  • Total development agreement could be worth up to $275 million
  • AB928 has the potential to reverse adenosine-induced immune suppression within the tumor microenvironment

... read more

Fri, 07/13/18 - 09:28 am
Advaxis Shares Jump After FDA Lifts Clinical Hold on Phase 1/2 Study
  • Shares up 38%+ in pre-market trading
  • Clinical Hold was issued on March 9, 2018
  • Axalimogene filolisbac has fast track designation for adjuvant therapy for high-risk locally... read more
Fri, 07/13/18 - 09:05 am
FDA Releases Six New Draft Guidances on Gene Therapy

On 7/11/2018 FDA Commissioner, Scott Gottlieb, announced the release of six new draft guidance documents related to gene therapy development. In the announcement, Gottlieb acknowledged the... read more

Thu, 07/12/18 - 09:51 am
Landos Biopharma Initiates Ph I Trial of First-in-class Oral Treatment for IBD
  • BT-11 is a first-in-class, oral, locally-acting small molecule
  • BT-11 has demonstrated a 90% reduction of inflammation by acting locally in the gut mucosa in 4 validated mouse models... read more
Thu, 07/12/18 - 09:17 am

Pages